As per the research report, the size of the Europe Cardiac Surgery Devices Market is valued at USD 0.44 billion in 2019 and estimated to be growing at a CAGR of 3.06%, to reach USD 0.52 billion by 2024 during the forecast period 2019-2024.
Cardiovascular surgery can be defined as the process which is performed to resolve the defects of heart tissue like replacing the diseased heart valves if they are blocked, replacement of heart tissues in case of damage and for grafting.
Among the many types of heart surgery include open heart surgery, modern beating heart surgery, heart transplant, coronary artery bypass surgery and minimally invasive surgeries. In an open-heart surgery, the heart of a patient is cut open and a surgery is performed on its internal structures. In a modern heart beating surgery, the heart continues to beat but it is stabilised to provide for a still working area. Heart transplant involves inserting a heart of one person into another person. Coronary artery bypass surgery involves creating an alternative path in order to deliver blood to heart and body.
The driving factors of Europe Cardiac Surgery Devices market are growth in prevalence and incidence of heart related diseases. Also, the growth in healthcare insurance and healthcare expenditure are expected to propel the market growth during the forecast period. However, the market is constrained due to factors such as and lack of awareness among the population and shortage of experienced healthcare professionals.
This research report segmented and sub-segmented into the following categories:
Europe has the third largest market for cardiac surgery devices in the world by share. Factors such as growing prevalence of heart diseases and rising healthcare expenditure are expected to drive the market growth during the forecast period.
Key players operating in the Europe Cardiac Surgery Devices Market profiled in this report are Trinity Biotech, Abiomed, Inc., Cardinal Health, C. R. Bard, Inc., MedWaves Incorporated, CyberHeart Incorporated and Transmedics, Inc. among others.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Cardiopulmonary Bypass Equipment
5.1.2 Beating Heart Surgery Systems
5.1.3 Perfusion Disposables
5.1.4 Cardiac Ablation Devices
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2 Application
5.2.1 Cardiac Arrhythmia
5.2.2 Coronary Heart Disease
5.2.3 Congenital Heart Defects
5.2.4 Congestive Heart Failure
5.2.5 Other Applications
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 Age Group
5.3.1 New-born (0-30 days)
5.3.2 Infant (31 days-1 year)
5.3.3 Children (1-18 years)
5.3.4 Adult (18+ years)
5.3.5 Y-o-Y Growth Analysis, By Age Group
5.3.6 Market Attractiveness Analysis, By Age Group
5.3.7 Market Share Analysis, By Age Group
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Product Type
6.1.3.2 By Application
6.1.3.3 By Age Group
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Product Type
6.1.4.2 By Application
6.1.4.3 By Age Group
6.1.5 Market Share Analysis
6.1.5.1 By Product Type
6.1.5.2 By Application
6.1.5.3 By Age Group
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Trinity Biotech
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abiomed, Inc.
8.3 Cardinal Health
8.4 C. R. Bard
8.5 MedWaves Incorporated
8.6 CyberHeart Incorporated
8.7 Transmedics, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
